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Abstract 
Background: Pleural infection affects about 65,000 patients annually in the US and UK. In this and other forms of 
pleural injury, mesothelial cells (PMCs) undergo a process called mesothelial (Meso) mesenchymal transition (MT), by 
which PMCs acquire a profibrogenic phenotype with increased expression of α-smooth muscle actin (α-SMA) and 
matrix proteins. MesoMT thereby contributes to pleural organization with fibrosis and lung restriction. Current murine 
empyema models are characterized by early mortality, limiting analysis of the pathogenesis of pleural organization 
and mechanisms that promote MesoMT after infection.
Methods: A new murine empyema model was generated in C57BL/6 J mice by intrapleural delivery of Streptococ-
cus pneumoniae (D39, 3 × 107–5 × 109 cfu) to enable use of genetically manipulated animals. CT-scanning and 
pulmonary function tests were used to characterize the physiologic consequences of organizing empyema. Histol-
ogy, immunohistochemistry, and immunofluorescence were used to assess pleural injury. ELISA, cytokine array and 
western analyses were used to assess pleural fluid mediators and markers of MesoMT in primary PMCs.
Results: Induction of empyema was done through intranasal or intrapleural delivery of S. pneumoniae. Intranasal 
delivery impaired lung compliance (p < 0.05) and reduced lung volume (p < 0.05) by 7 days, but failed to reliably 
induce empyema and was characterized by unacceptable mortality. Intrapleural delivery of S. pneumoniae induced 
empyema by 24 h with lung restriction and development of pleural fibrosis which persisted for up to 14 days. Markers 
of MesoMT were increased in the visceral pleura of S. pneumoniae infected mice. KC, IL-17A, MIP-1β, MCP-1, PGE2 and 
plasmin activity were increased in pleural lavage of infected mice at 7 days. PAI-1−/− mice died within 4 days, had 
increased pleural inflammation and higher PGE2 levels than WT mice. PGE2 was induced in primary PMCs by uPA and 
plasmin and induced markers of MesoMT.
Conclusion: To our knowledge, this is the first murine model of subacute, organizing empyema. The model can be 
used to identify factors that, like PAI-1 deficiency, alter outcomes and dissect their contribution to pleural organiza-
tion, rind formation and lung restriction.
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Background
Pleural infection remains a common and important clini-
cal problem that can complicate pneumonia or occur 
after trauma. The incidence of empyema continues to rise 
despite the broad use of vaccinations and development of 
more potent antibiotics [1, 2]. Of the roughly 4 million 
cases of pneumonia annually diagnosed in the US, about 
half develop a parapneumonic effusion [1]. In many 
cases, these effusions can evolve with formation of com-
plicated parapneumonic effusions or frank empyema, 
which is characterized by overt infection or intrapleural 
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pus. Biomarkers such as low pH predict the development 
of pleural loculation [1]. About 65,000 patients in the 
US and UK suffer from pleural infection each year [1, 3], 
which is associated with increased morbidity, mortality 
and medical costs approaching half a billion dollars annu-
ally [4, 5]. About 40,000 US patients annually may require 
pleural drainage to prevent morbidity associated with 
complicated parapneumonic effusions/empyema in the 
US each year [6]. Current surgical treatment is invasive 
and alternative treatment with intrapleural administra-
tion of fibrinolysins is associated with variable outcomes 
in adults [7]. These considerations justify the search for 
more effective interventions, which rely on better under-
standing of the pathogenesis of pleural organization and 
remodeling [8].
In a previous publication, we showed that a combina-
tion of bleomycin and carbon black (CBB) could reli-
ably and reproducibly induce pleural injury including 
reduced lung function and increased pleural thickening 
in C57BL/6 mice [9]. We also reported a Pasteurella mul-
tocida model of pleural injury in rabbits [10]. Although 
this injury is quite robust, simulates human pleural injury 
and has been used to test the efficacy of fibrinolytic 
agents, this pathogen rarely causes pleural infection in 
clinical practice. Because the use of larger animals limits 
use of transgenic or knock-out animals, a murine model 
of pleural injury and repair in the C57BL/6 strain is desir-
able. While a previous study showed that intranasally 
administered S. pneumoniae (D39 strain) produced intra-
pleural injury in CD1 mice, that model was characterized 
by early mortality that restricted analyses to the acute 
setting; over 48 h [11]. Pleural infection was lethal there-
after, precluding analysis of the remodeling that occurred 
after acute injury. To our knowledge, no murine model of 
empyema and progressive pleural organization after bac-
terial infection has been reported, which has slowed pro-
gress in the field. We inferred that a more durable model 
of infectious pleural injury could be developed and tested 
that postulate using C57BL/6 mice to develop a model of 
organizing of S. pneumoniae pleural empyema with sur-
vivorship over 2 weeks. We used the model to assess the 
impact of PAI-1 deficiency on the evolution of organizing 
empyema, as this derangement was previously reported 
to increase pleural rind formation and lung restriction in 
the CBB model of noninfectious pleural injury [9].
Methods
Intranasal and intrapleural inoculations
All experiments involving animals were approved 
by the Institutional Animal Care and Use Commit-
tee at the University of Texas Health Science Center 
at Tyler. C57BL/6  J mice (10–12  weeks of age, ≈20  g, 
Jackson Laboratory, Bar Harbor ME) were lightly 
anesthetized with isoflurane. Intranasal inoculations 
(3 × 107–5 × 109) of Streptococcus pneumoniae (S. pneu-
moniae, D39, National Collection of Type Cultures, 
Salisbury UK) resuspended in 0.9  % saline were deliv-
ered in 40  µl over the nares. Intrapleural inoculations 
(5  ×  107–5  ×  108  cfu, resuspended in 0.9  % saline) of 
S. pneumoniae were delivered in 150 µL by intrapleural 
injection. The control group received normal saline 
under the same conditions. Antibiotic treatment (enro-
floxacin, 15  mg/kg) was initiated 18  h post infection 
and was administered daily by subcutaneous injection 
for 4  days. Mice were periodically monitored follow-
ing infection to record body weight, dehydration sta-
tus, activity and behavior. If dehydration was detected 
by alterations of skin turgor, the affected mice were 
subcutaneously injected with 200–500  µl of warmed 
0.9 % saline, as needed. Moribund animals were eutha-
nized. After administration of S. pneumoniae, mice were 
housed on a heating pad to maintain an ambient temper-
ature of 30 °C throughout the time course.
Lung and pleural lavage collection
Lung and pleural lavages were performed using 1.5 ml of 
sterile normal saline were immediately performed at the 
time of death in selected animals, as previously described 
[9]. Total white cell and differential cell counts were like-
wise measure in these fluids, as we previously reported 
[9].
Cultures of pleural fluids
Pleural lavages of saline and S. pneumoniae infected mice 
were cultured on blood agar plates containing 5 % sheep 
blood (Remel Blood Agar, Fisher Scientific). Neat (50 µl) 
and 1:100 dilutions of the pleural lavages were cultured 
on blood agar plates and incubated 15 h at 37 °C. Colo-
nies were then counted to determine bacterial burden.
Lung histology, immunostaining, confocal, bright field 
microscopy and morphometry
Lung histology and immunostaining were performed as 
previously described [9, 12]. All tissue sections were first 
deparafinized and subjected to antigen retrieval using a 
citrate buffer at 95  °C for 20  min. Tissue analyses, col-
lagen deposition and localization were initially assessed 
by Trichrome staining as previously described [9, 12]. 
Morphometric analyses of pleural tissue thickness and 
depth of underlying pneumonitis were performed as 
we previously described [9]. Fibrin (ogen) antigen was 
assessed using immunohistochemistry (IHC) and Fast 
Red (BioGenex, Freemont CA) chromogen as previously 
described [13].
Immunofluorescence was used to visualize α-SMA and 
calretinin expression in saline and S. pneumoniae infected 
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pleuropulmonary sections as previously described [9]. 
Confocal microscopy was then used to visualize immu-
nofluorescence and co-localization of the markers. Con-
focal images were acquired from a field of view at 0.4-µm 
z-axis increments with the LSM 510 Meta confocal sys-
tem (Carl Zeiss) at 40× as previously described [9, 13].
Collagen detection in lung tissues
Bright field microscopy was used to image trichrome 
stained tissue sections as previously described [9]. Col-
lagen was detected by picrosirius staining and imaged 
using a polarized light source on a Nikon Ti inverted 
microscope.
Pulmonary function testing
Pulmonary function tests were performed immedi-
ately before CT imaging and prior to sacrifice, as previ-
ously described [9, 12]. Briefly, mice were anesthetized 
with a ketamine/xylazine mixture. Anesthetized mice 
were intubated by inserting a sterile, 20-gauge intrave-
nous cannula through the vocal cords into the trachea. 
Measurements were then performed using the flexiVent 
system (SCIREQ, Tempe AZ). The “snapshot perturba-
tion method” was used to determine lung compliance, 
according to manufacturer’s specifications. Mice were 
maintained under anesthesia using isoflurane during pul-
monary function testing.
Computed tomography (CT) scans and measurements 
of lung volume
Chest CT imaging and measurements of lung volume 
were performed as previously described [9, 12]. Keta-
mine/xylazine anesthetized mice were anesthetized fur-
ther using an isoflurane/oxygen mixture to minimize 
spontaneous breaths and to ensure that mice remained 
anesthetized throughout the procedure. Images were 
obtained using the Explore Locus Micro-CT Scanner. CT 
scans were performed during full inspiration and at a res-
olution of 93 µm. Microview software was used to ana-
lyze lung volumes and render three-dimensional images. 
Lung volumes were calculated from renditions collected 
at full inspiration.
Measurement of pleural fluid plasmin and fibrinolytic 
activity
Plasmin activity in the pleural washes of WT and PAI-
1−/− mice treated with saline or S. pneumoniae was 
measured by amidolytic assay using a plasmin substrate 
(PL-5268, Centerchem Inc, Norwalk CT) on a Spec-
traMax 96-well optical absorbance plate reader (Molec-
ular devices, Sunnyvale, CA), as previously described 
[14]. Fibrinolytic activity was measured as previously 
described [14].
Bioplex analyses of pleural lavage mediators
Analyses of pleural lavage inflammatory mediators 
including: Eotaxin, G-CSF,GM-CSF,IFN-γ, IL-1α, IL-1β, 
IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p40), IL-12 
(p70), IL-13, IL-17A, KC, MCP-1 (MCAF), MIP-1α, 
MIP-1β, RANTES, TNF-α were determined using the 
Bio-Plex Pro Mouse Cytokines 23-plex (BIO-RAD) on 
a BioPlex MAGPIX Multiplex Reader according to the 
manufacturer’s instructions.
PGE2 ELISA
PGE2 was first extracted from pleural lavage by C18 
column purification according to manufacturer’s direc-
tions (Cayman Chemical, Ann Arbor Michigan). PGE2 
levels were determined by competitive ELISA (Cayman) 
according to manufacturer’s instructions.
Primary pleural mesothelial cell culture and treatment
Permission to collect and use HPMCs was granted 
through an exempt protocol approved by the Institu-
tional Human Subjects Review Board of the University 
of Texas Health Science Center at Tyler. HPMCs were 
isolated from pleural fluids collected from patients with 
congestive heart failure or post-coronary bypass pleu-
ral effusions as previously described [15]. HPMCs were 
maintained in LHC-8 culture media (Life Technologies, 
Carlsbad CA) containing 3  % fetal bovine serum (Life 
Technologies), 2  % antibiotic–antimycotic (Life Tech-
nologies) and Glutamax (Life Technologies) as previously 
described [9, 13, 15, 16]. MPMCs were isolated and cul-
tured as previously reported [9]. All cells were cultured in 
a humidified incubator at 37 °C in 5 % CO2/95 % air. Cells 
were passaged a maximum of five times before discon-
tinuing use. Serum-starved cells were treated with TGF-β 
(5 ng/ml), PGE2 (1 µM), butaprost (EP2 agonist, 1 µM), 
sulprostone (EP3 agonist, 1  µM) and Cay10598 (EP4 
agonist, 1 µM, Cayman). Cell lysates were then Western 
blotted for α-SMA and β-actin as previously described [9, 
17].
Statistics
All statistics were performed using the Mann–Whit-
ney U test. A p value of less than 0.05 was considered 
significant.
Results
Intranasal administration of S. pneumoniae did not reliably 
induce survivable empyema
To create a model of pneumonia complicated by empy-
ema, we initially challenged C57BL/6 mice with intra-
nasal administration of S. pneumoniae. A range of doses 
were used to induce empyema in dose–response analy-
ses (3 ×  107–5 ×  109 cfu). Intranasal administration of 
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S. pneumoniae (3 × 108 CFU) significantly reduced lung 
volume (Fig.  1a, p  <  0.01) and decreased compliance 
(p < 0.01). As previously reported [11], intranasal admin-
istration of S. pneumoniae was associated with significant 
mortality without antibiotics (data not shown), so that a 
quinolone to which the organism is exquisitely suscepti-
ble was begun at 18 h. Doses of less than 3 × 108 cfu did 
not induce detectable changes in lung function. A range 
of higher intranasal doses (up to 109  CFU) consistently 
caused early mortality (<24 h) associated with severe dif-
fuse pneumonitis, pleural inflammation and pleural effu-
sions and were not further investigated (data not shown). 
Tissue sections from saline and infected mice were next 
analyzed to assess changes in lung histology and collagen 
deposition. Alveolar inflammation was apparent at 7 days 
after 3 × 108 CFU and mild reactive changes of the vis-
ceral pleurae were consistently observed (Fig. 1b). Pleural 
thickness was not significantly increased by intranasal S. 
pneumoniae infection (data not shown). No pleural effu-
sions or adhesions were found at 7 days in any of these 
animals, indicating that pleural injury was relatively mild 
in animals treated with a maximal, survivable intranasal 
dose of the organism.
Intrapleural administration of S. pneumoniae induces 
pleural organization and remodeling with rind formation
Because of the lack of pleural organization with suble-
thal doses of intranasally administered S. pneumoniae, 
we next sought to determine if intrapleural administra-
tion yielded survivable empyema. S. pneumoniae was 
therefore injected directly into the pleural space, at a 
range of doses (5 × 107–5 × 108 cfu) with no antibiotic 
coverage. We found that doses of less than 1 × 108 CFU 
did not reliably induce pleural injury, while doses above 
3 × 108 cfu were associated with unacceptable early mor-
tality of almost all animals (data not shown). S. pneumo-
niae infected mice demonstrated dramatic decrements 
in weight for the first 3 days after infection (Fig. 2a). By 
7  days, the infected mice had regained most of the lost 
weight. In initial analyses, mice were euthanized 7  days 
after S. pneumoniae administration. Gross analyses of 
infected mice showed increased deposition of transitional 
Fig. 1 Intranasal S. pneumoniae causes pneumonia, lung dysfunction and mild pleural inflammation at survivable intranasal dosing. S. pneumoniae 
(3 × 108CFU) was intranasally administered to WT mice and maintained for 7 days. a Lung volumes were measured by CT scan and pulmonary 
function (compliance) measured as described in the Methods. n = 6–7 mice/group. b Peripheral lung tissue sections from saline-challenged and 
S. pneumoniae infected mice collected at 7 days were stained with trichrome to show changes in lung architecture and collagen deposition (blue 
stain). S. pneumoniae infected mice exhibited thickened alveolar septae, mild pleural inflammation, reactive visceral mesothelial cells and mildly 
increased collagen deposition compared to saline controls. No pleural fluid or fibrinous strands at the pleural surface were seen. Solid arrows indi-
cate reactive mesothelial cells. Images are 40× and are representative of the findings of 30 fields/slide and 6–7 mice/group
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fibrinous adhesions in the pleural space (Fig. 2b) and the 
pleural surface was coated with what grossly appeared 
to be purulent material by 2 days (data not shown). This 
injury progressively worsened over 7  days, with pleu-
ral thickening detectable by 5  days (not shown) and 
increased by 7  days, often with areas of discrete pleu-
rodesis. As anticipated based on the gross findings, intra-
pleural administration of S. pneumoniae significantly 
impaired lung volume (p  <  0.05) and lung function; 
compliance (p  <  0.05) by 7  days (Fig.  2c). By histologic 
analysis, infected mice exhibited extensive remodeling 
characterized by significant pleural thickening with colla-
gen deposition (blue stain) at 7 days compared to saline-
treated controls (Fig. 2d). Ultimately, we found that this 
model was limited by mortality of greater than half of the 
animals by 7 days, which was unacceptable.
Antibiotic treatment improves survival of mice 
intrapleurally infected with S. pneumoniae
To expand the experimental time frame so that pleural 
organization and remodeling could be interrogated over 
7–14  days, intrapleurally infected mice were given an 
antibiotic; enrofloxacin, 18  h after intrapleural adminis-
tration of S. pneumoniae (1.8 ×  108). Antibiotic-treated 
S. pneumoniae-infected mice demonstrated rapid weight 
loss by 3  days after infection (Fig.  3a), similar to mice 
without antibiotic treatment. However, these mice began 
to gain weight by 4  days and approached saline control 
levels by 6  days. Gross analyses (Fig.  3b) showed pro-
nounced pleural injury in antibiotic-treated, S. pneumo-
niae infected mice at 7 days (panel b) when compared to 
saline treated mice (panel a). 
We next performed pulmonary function tests and CT 
scans at 7 days in these mice and found consistent decre-
ments in lung volume (p < 0.01) and pulmonary function; 
compliance (p  <  0.01), versus saline controls (Fig.  3c). 
Total WBC were significantly elevated (17.7 ± 7.8 × 105 
versus 8.6  ±  2.3  ×  105 p  <  0.01, n  =  8) in the pleural 
lavages of infected mice compared to saline controls at 
7 days with antibiotic treatment. The median neutrophil 
percentage was 25 % at 7 days in the empyema animals 
and was 1 % in the saline controls. Tissue sections from 
saline and S. pneumoniae infected mice were next ana-
lyzed by histology. Because parietal pleural injury was 
more heterogeneous and responses of the visceral and 
parietal pleural surfaces were found to be comparable, 
we focused on determination of changes in the visceral 
pleura, as we previously reported [9]. S. pneumoniae 
infected mice exhibited pronounced matrix deposition 
and significant pleural thickening (p  <  0.001, Fig.  3d) 
compared to saline controls. The infection also induced 
collagen expression in the mesothelium and subpleural 
mesothelium by 7  days as determined by Picrosirius 
staining for collagen (red–orange birefringence, Fig. 4a). 
Tissue sections from saline and S. pneumoniae-infected 
mice were next stained for fibrin(ogen) by immunohis-
tochemistry (red stain, Fig.  4b). Robust fibrin (ogen) 
deposition was detected at the visceral pleural surface 
7  days post-infection. That both fibrin(ogen) and col-
lagen are detectable in the thickened visceral pleura by 
7 days after S. pneumoniae injury indicates that ongoing 
pleural organization contributed to the restrictive, physi-
ologic alterations we observed at this time. Pleural lavage 
from euthanized saline and S. pneumoniae infected mice 
were cultured on blood agar dishes to determine if live S. 
pneumoniae persisted throughout the 7 days time course. 
With antibiotic treatment, pleural lavages were ster-
ile by 7  days after intrapleural inoculation, while live S. 
pneumoniae were routinely cultured from the lavages of 
7 days infected mice that were not treated with antibiot-
ics. In time course experiments, S. pneumoniae colonies 
could not be detected in pleural lavage by 3  days after 
antibiotic administration (data not shown).
Because antibiotic treatment increased survival of 
infected mice, we next extended the model over 14 days 
and determined the effect of S. pneumoniae infection on 
pulmonary function (Fig.  4c). Significant decrements in 
lung volume (p < 0.01) and pulmonary function; compli-
ance (p  <  0.01) persisted at 14  days. Increased collagen 
deposition (blue stain) and significant increases in pleural 
thickness remained at 14 days (Fig. 5a). Underlying pneu-
monitis was detected in S. pneumoniae infected mice at 
(See figure on previous page.) 
Fig. 2 Intrapleural S. pneumoniae induces pleural injury and lung dysfunction. S. pneumoniae was intrapleurally administered and incubated for 
7 days. a Weights were collected over 7 days (n = 3–7 mice/group). b Gross images taken at 7 days after administration of saline or S. pneumoniae. 
These animals did not receive antibiotic treatment. S. pneumoniae infection promotes extensive pleural injury with deposition of a transitional 
intrapleural fibrinous neomatrix that is readily appreciated with coating and encasement of the lungs. Solid arrows indicate areas of neomatrix 
deposition within the thoracic cavity of S. pneumoniae infected mice. c Lung volumes and function (compliance) were significantly reduced by S. 
pneumoniae administration at 7 days (p < 0.05). d Lung tissue sections from saline-treated and S. pneumoniae infected mice (7 days post-infection) 
were trichrome stained, with collagen deposition indicated by the blue stain. By morphometry, S. pneumoniae infected mice demonstrated signifi-
cantly more pleural thickening than saline controls (p < 0.001). Solid arrows indicate the pleural surface and the basement membrane of the thick-
ened pleura. Areas of collagen deposition were observed within the thickened pleural rind of S. pneumoniae infected mice. Images were obtained 
at 20× and are representative of the finding of 30 fields/slide and 3–7 mice/group
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Fig. 3 Antibiotic treatment extends survival after S. pneumoniae-induced empyema which is characterized by persistent pleural fibrosis, rind forma-
tion and lung restriction. Antibiotic treatment was begun 18 h after S. pneumoniae was intrapleurally administered. a Weights were collected over 
a 7 days time course (n = 8 animals/group). The infected mice recovered lost weight by 6 days. b Gross images were taken 7 days after intrapleural 
administration of saline or S. pneumoniae. S. pneumoniae infection promotes progressive pleural injury and deposition of a fibrinous matrix with 
antibiotic treatment (subpanel B) when compared to saline controls (subpanel A). Representative images are shown (n = 6–8 animals/group). c Lung 
volumes and function (compliance) were significantly reduced by S. pneumoniae infection by 7 days (P < 0.01). d Lung tissue sections from saline 
and S. pneumoniae infected mice were trichrome stained for collagen deposition (blue). Solid arrows indicate the pleural surface and the basement 
membrane of the thickened pleura. Areas of collagen deposition were observed within the thickened pleural rind of S. pneumoniae infected mice. S. 
pneumoniae-infected mice had significantly increased pleural thickening when compared to saline controls (6–8 mice/group)
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14  days mice. Pleural fibrin deposition and intrapleural 
adhesions were likewise detectable at this time (data not 
shown). Collagen deposition, by picrosirius staining, per-
sisted in 14  days infected WT mice compared to saline 
controls (Fig. 5b). Pleural thickening did not significantly 
change between 7 and 14 days.
Mediator Profile in pleural fluids of S. pneumoniae infected 
mice
We next sought to characterize the profile of locally elabo-
rated mediators promoting significant increases in WBC 
that were observed in pleural fluids of infected mice. We 
first measured changes in inflammatory mediators. KC, 
Fig. 4 S. pneumoniae-induced empyema is characterized by persistent pleural fibrosis, rind formation and lung restriction at 7 days. Antibiotic treat-
ment was begun 18 h after S. pneumoniae was intrapleurally administered. a Peripheral lung sections from saline and S. pneumoniae infected mice 
were picrosirius stained to detect collagen deposition (red–orange birefringence). S. pneumoniae infected mice demonstrated increased collagen 
deposition at the pleural surface and in the subpleural region compared to saline-treated mice. Solid arrows indicate the basement membrane and 
the visceral pleural surface. Areas of collagen deposition were detected at the basement membrane and within the thickened pleural mesothelium. 
b Tissue sections from 7 days saline and S. pneumoniae infected mice were stained for fibrin (ogen) by immunohistochemical analysis (red stain). 
Extravascular fibrin (ogen) deposition is readily apparent after S. pneumoniae infection. Solid arrows indicate the pleural surface and the basement 
membrane of the thickened pleura of S. pneumoniae infected mice. Fibrin(ogen) deposition was prominent at the pleural surface of S. pneumoniae 
infected mice. c Lung volumes and function (compliance) were significantly decreased by S. pneumoniae infection by 14 days (p < 0.01)
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IL-17A, MIP-1β and MCP-1 were significantly increased 
with S. pneumoniae infection by 7  days (p  <  0.05) but 
were not significantly different from control levels by 
14 days (Fig. 6a). Conversely, IL-13, an anti-inflammatory 
cytokine was significantly down-regulated (p  <  0.01) in 
S. pneumoniae-infected mice by 7  days but returned to 
saline controls levels by 14  days. Eotaxin, G-CSF,GM-
CSF,IFN-γ, IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, 
IL-10, IL-12 (p40), IL-12 (p70), MIP-1α, RANTES, TNF-α 
were not significantly changed at 7 and 14  days post 
infection. PGE2, an inflammatory cytokine found to be 
increased in pleural injury [18], was likewise increased in 



















Fig. 5 S. pneumoniae-induced empyema is characterized by persistent pleural fibrosis, rind formation and lung restriction at 14 days. Antibiotic 
treatment was begun 18 h after S. pneumoniae was intrapleurally administered. a Lung tissue sections from saline and S. pneumoniae-treated mice 
were Trichrome stained to assess collagen deposition (blue) and determine pleural thickness. 14 days S. pneumoniae-infected mice exhibited signifi-
cantly increased pleural thickening compared to saline controls. Solid arrows indicate the pleural surface and the basement membrane of the thick-
ened visceral pleura. Broken arrows indicate areas of pneumonitis underlying the thickened pleura. Collagen deposition was detected within the 
pleural mesothelium of S. pneumoniae infected mice. Images were collected at 20× and are representative of 30 fields/slide and 6–8 mice/group. 
b Lung tissue sections from saline and S. pneumoniae treated mice were stained with picrosirius to confirm tissue collagen deposition (red–orange 
birefringence). S. pneumoniae infected mice demonstrated increased collagen deposition at the pleural and subpleural space when compared 
to saline-treated mice at 14 days. Solid arrows indicate areas of collagen deposition within the mesothelium of the visceral pleura of saline and S. 
pneumoniae infected mice. Images were taken at 20× and are representative of 30 fields/slide and 6–8 mice/group
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these pleural lavage samples versus saline control mice at 
7 days post-induction of empyema (Fig. 6b).
pneumoniae‑mediated pleural injury is characterized 
by prominent visceral pleural MesoMT
We previously showed that MesoMT of visceral pleural 
mesothelial cells likely contributes to the formation of 
the pleural rind associated with non-specific pleuritis in 
human tissues [9]. The contribution of MesoMT to pleu-
ral rind formation was also confirmed in carbon black/
bleomycin-mediated pleural injury [9]. We next sought 
to determine the contribution of MesoMT to pleural 
remodeling in S. pneumoniae-mediated pleural injury 
using confocal microscopy. Saline treated mice were 
positive for the mesothelial protein; calretinin (green) but 
did not express the myofibroblast marker; α-SMA (red, 
Fig.  7) in the mesothelium and submesothelial tissues. 
Conversely, α-SMA expression was enhanced at the pleu-
ral surface and colocalized with calretinin in S. pneumo-
niae-infected mice. These findings strongly suggest that 





















































































































































Fig. 6 Inflammatory cytokine profile of S. pneumoniae infected mice. Lavages were isolated from the pleural cavities of saline and intrapleurally 
infected S. pneumoniae infected mice 7 and 14 days post infection. a Proinflammatory mediator expression was then assayed in the collected lav-
ages by Bioplex assay. Pleural lavages showed significant changes in KC, IL-17A, MCP-1, MIP-1β, and IL-13 at 7 days by Bioplex analyses (P < 0.01). 
n = 6–8 mice/group. PGE2 was extracted from the PLs of saline and S. pneumoniae-infected mice. PGE2 levels were then determined by competitive 
ELISA. b PGE2 expression was significantly increased in the lavages of S. pneumoniae infected WT mice at 7 days (*denotes a P < 0.05), n = 6–8 mice/
group
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MesoMT of resident pleural mesothelial cells localizes to 
and contributes to the extensive pleural rind formation 
and remodeling associated with S. pneumoniae-induced 
pleural organization.
PAI‑1 deficiency worsens S. pneumoniae pleural injury 
at 3 days post‑infection
We recently showed that PAI-1 deficiency exacerbated 
carbon black/bleomycin-mediated pleural injury [9]. 
To interrogate the role of PAI-1 in the progression of S. 
pneumoniae empyema, PAI-1−/− mice were used. Unlike 
WT mice, infected PAI-1−/− mice that received anti-
biotic treatment demonstrated significant mortality by 
4  days (data not shown) so that we could only reliably 
maintain these animals over 3 days. Although these ani-
mals only received 2  days of the antibiotic regimen, no 
bacteria were detected in the pleural washes of either 
WT or PAI-1 infected mice at 3 days (data not shown). 
While infected PAI-1−/− mice demonstrated significant 
changes in lung volume (p  =  0.02) by 3  days (Fig.  8a), 
trends in infected WT mice did not reach significance by 
3  days. S. pneumoniae-infected WT and PAI-1−/− mice 
exhibited significant changes in compliance when com-
pared to the saline controls (p = 0.03 versus 0.01 respec-
tively). Total WBC counts in pleural lavage were also 
significantly increased in S. pneumoniae infected WT 
(1.16 ±  0.24 ×  106 versus 11.51 ±  4.7 ×  106, p  <  0.05) 
and PAI-1−/− (1.46 ± 0.80 × 106versus 12.7 ± 3.01 × 106, 
n = 4–6 mice/group, p < 0.05) versus saline controls. The 
percentage of lavage neutrophils was also significantly 
increased in PAI-1−/− deficient mice (p < 0.0001, Fig. 8b).
Tissue sections from S. pneumoniae-infected WT and 
PAI-1−/− mice were next stained for fibrin (ogen) by IHC 
(Fig. 8c). S. pneumoniae infected PAI-1−/− mice demon-
strated decreased pleural fibrin deposition that was read-
ily apparent compared to WT mice treated in the same 
manner. Extravascular fibrin (ogen) was not detected in 
saline treated mice (data not shown). Tissues from 3 days 
infected WT and PAI-1−/− mice were also stained for 
α-SMA to determine the extent of MesoMT. However 
there were no differences between infected WT and PAI-
1−/− mice at 3 days (data not shown).
We next determined the inflammatory mediator pro-
file in pleural lavage of 3 days WT and PAI-1−/− infected 
mice. WT and PAI-1−/− S. pneumoniae infected mice 
demonstrated significant increases in KC, IL-4, IL-5, 
IL-6, IL-10, IL-12, MCP-1, G-CSF and MIP-1β (Fig.  9, 
P  <  0.05) compared to the saline controls. However 
there were no significant differences between WT and 
PAI-1−/− mice, saline or infected. Conversely, IL-13 
expression was significantly decreased in WT mice with 
infected with S. pneumoniae (p < 0.05) at 3 days. While 
Fig. 7 Mice with S. pneumoniae empyema demonstrate increased α-SMA in the mesothelium of the visceral pleura. Peripheral lung tissue sections 
from saline and S. pneumoniae-infected mice were prepared from the lungs of mice with empyema that progressed over 7 days. The sections were 
then probed for calretinin (green) and α-SMA (red) expression in the pleural mesothelium and observed by confocal microscopy. Solid arrows indi-
cate areas of α-SMA and calretinin colocalization at the surface and within the thickened visceral pleura of S. pneumoniae infected mice. All images 
were taken at 40× magnification. Images are representative of 30 fields/slide and n = 5–6 mice/group








































































































Fig. 8 Pleural inflammation and lavage neutrophilia is increased in PAI-1 deficiency after induction of S. pneumoniae mediated pleural injury. 
Pleural injury was induced in WT and PAI-1−/− mice by intrapleural injection of S. pneumoniae and maintained for 3 days. CT scan and pulmonary 
function analyses were performed 3 days after infection. a S. pneumoniae infection induced significant pleural injury in PAI-1−/− mice (volume and 
compliance, p = 0.02 and p = 0.01, respectively). b Pleural lavage fluid from S. pneumoniae infected PAI-1−/− mice contained a significantly higher 
percentage of neutrophils than identically treated WT mice. Neutrophil percentage was determined by differential staining and cellular differential 
performed at 100× oil magnification, n = 4–7/group. c Tissue sections from saline and S. pneumoniae-infected mice were prepared from the lungs 
of WT and PAI-1−/− mice after 3 days. The sections were then stained for fibrin (ogen) (red) by IHC. All images were taken at 20× magnification. 
Images are representative of 30 fields/slide and n = 4–7 mice/group. Pleural lavages (PL) were performed on S. pneumoniae infected mice at 3 days









































































































































































































































































































































Fig. 9 Pleural inflammation and lavage neutrophilia is increased in PAI-1 deficiency after induction of S. pneumoniae mediated pleural injury. Pleural 
injury was induced in WT and PAI-1−/− mice by intrapleural injection of S. pneumoniae for 3 days. PLs from saline and S. pneumoniae-infected WT 
and PAI-1−/− mice demonstrated significant increases in KC, IL-4, IL-5, IL-6, IL-10, IL-12, MCP-1, G-CSF, and MIP-1β * denotes P < 0.05, n = 4–7 mice/
group). S. pneumoniae infection significantly decreased IL-13 in WT mice (p < 0.05) when compared to controls. Saline-treated PAI-1−/− mice dem-
onstrated significantly less IL-13 than similarly treated WT mice (p < 0.05). n = 4–7 mice/group 
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IL-13 levels in saline treated PAI-1−/− mice were not sig-
nificantly different from S. pneumoniae infected PAI-1−/− 
mice, they were significantly lower than saline treated 
WT mice (p < 0.05).
PGE2 and plasmin are increased in PAI‑1
−/− mice 
with empyema
Because PGE2 was significantly increased in the pleural 
lavages of 7  days S. pneumoniae-infected WT mice, we 
next assayed PGE2 levels in the pleural lavages of 3  day 
infected WT and PAI-1−/− mice. PGE2 levels were signif-
icantly increased in the pleural lavages of S. pneumoniae-
infected PAI-1 deficient mice compared to identically 
treated WT mice at 3 days (p < 0.05, Fig. 10a). Because 
plasmin has been reported to increase COX-2 and, con-
sequently, PGE2 expression [19], we next assayed plasmin 
activity in the pleural lavages of WT and PAI-1−/− mice 
(Fig.  10b). As anticipated, plasmin activity was signifi-
cantly increased in the pleural lavage of S. pneumoniae-
infected WT and PAI-1−/− mice compared to saline 
controls (P  =  0.05 and 0.02 respectively). Further, S. 
pneumoniae infected-PAI-1−/− mice demonstrated sig-
nificantly higher plasmin activity than infected WT mice 
(p  =  0.04). These findings were confirmed by measur-
ing the fibrinolytic potential of these fluids using FITC-
labeled fibrin as previously described (data not shown) 
[14].
PGE2 induces MesoMT
Our data suggest that increased plasmin activity in the 
pleural fluids of S. pneumoniae infected PAI-1 deficient 
mice may contribute to induction of PGE2. uPA is also 
increased in pleural lavage of injured PAI-1−/−mice [9]. 
Therefore, we next tested the ability of uPA and plasmin 
to induce cyclooxygenase-2 (COX-2) and PGE2 in human 
(H) and murine (M) PMCs. uPA- and plasmin induced 
COX-2 and significantly increased PGE2 expression by 
HPMCs (Fig. 11a, b, respectively) and MPMCs (Fig. 11c, 
d, respectively). Because PGE2 was increased in pleu-
ral injury and increased PGE2 levels occurred in pleural 
lavage of PAI-1−/− mice, we next determined the ability 
of PGE2 to induce biomarkers of MesoMT using PMCs. 
PGE2 induced α-SMA protein expression in HPMCs 
and MPMCs (Fig.  12a, b respectively). TGF-β was used 
as a positive control in both HPMCs and MPMCs as it 
is an established stimulus of biomarkers of MesoMT; 
α-SMA in HPMCs [9, 17]. Phenotypic changes indica-
tive of MesoMT and increased α-SMA expression were 
detected in PGE2- and TGF-β-treated HPMCs (Fig. 12c). 
Because PGE2 induced α-SMA expression, we next 
sought to determine which prostaglandin receptor (EP) 
was responsible for PGE2-induced α-SMA. HPMCS 
were treated with TGF-β and butaprost (EP2 agonist), 
sulprostone (EP3 agonist) or Cay10598 (EP4 agonist). 
β-actin was the loading control. While butaprost and 
Cay10598 had no effect on α-SMA expression (data not 
shown), sulprostone robustly induced α-SMA expression 
(Fig. 12d). We attempted to down-regulate the EP recep-
tors (2–4) by siRNA transfection but were unable to suf-
ficiently reduce EP receptor expression for our analyses.
Discussion
Although the incidence of empyema continues to 
increase worldwide [1, 20], advances in its treatment 
remain relatively limited. Bacteriological analyses of the 
participants in the first Multicenter Intrapleural Sepsis 
Fig. 10 PGE2 and plasmin levels are increased in PAI-1 deficiency 
after induction of S. pneumoniae mediated pleural injury. Pleural 
injury was induced in WT and PAI-1−/− mice by intrapleural injection 
of S. pneumoniae and maintained for 3 days. PGE2 was extracted 
from the PLs of saline and S. pneumoniae-infected mice. PGE2 levels 
were then determined by competitive ELISA. a PGE2 was significantly 
higher in S. pneumoniae infected PAI-1−/− mice compared to infected 
WT mice at 3 days, n = 4–7 mice/group. * denotes (P < 0.05). b PLs 
from saline and S. pneumoniae infected WT and PAI-1−/− mice were 
assayed for plasmin activity. S. pneumoniae infection significantly 
increased plasmin activity in WT and PAI-1−/− mice (p = 0.05 and 
0.02, respectively) by 3 days. S. pneumoniae-infected PAI-1−/− mice 
demonstrated significantly higher plasmin activity than identically 
treated WT mice (p = 0.04)
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Trial (MIST1) showed that the leading causes of pleural 
infection are Streptococcal pathogens [1, 21, 22]. Fur-
ther, the leading microbial cause of community-acquired 
pneumonia is now Streptococcus pneumoniae [22]. The 
12  month mortality rate associated with pulmonary S. 
pneumoniae infection is reported to be about 17 % [22]. 
There has been little improvement in the mortality rate 
due to pleural infection in the US for the last 5 decades 
despite therapeutic advances including vaccination to 
protect against Streptococcal pneumonia [2]. These con-
siderations suggest an imperative to better understand 
mechanisms that contribute to pleural injury and iden-
tify new pathways and targets amenable to intervention. 
These efforts have been impeded by the lack of a surviv-
able murine model that reliably allows investigation of 
the pathogenesis of pleural organization and remodeling.
Our objective was to therefore develop a murine model 
that enables the assessment of organizing pleural injury 
after acute infection. We chose to develop the model 
in C57BL/6 mice so that investigators in the field could 
use the model in genetically engineered animals that 
are commonly available in this strain. An alternative 
model of murine Streptococcal empyema was originally 
reported in CD1 mice by Wilkosz et  al. [11]. However, 
the model was lethal at 48 h, which precludes analyses of 
subsequent changes that promote pleural organization 
and lung restriction. Another model has been reported in 
rabbits intrapleurally infected with Pasteurella multocida 
[10]. Although this model is quite robust and amenable 
to intervention with fibrinolytic agents, a major limita-
tion is that the organism rarely causes pleural disease in 
humans.
Because pleural infection most commonly occurs as 
a complication of pneumonia, we initially attempted to 
model these circumstances through nasal delivery of S. 
pneumoniae into the lungs and monitored the develop-
ment of empyema. Intranasal administration of S. pneu-
moniae-induced pneumonia with severe parenchymal 
inflammation and restrictive lung physiology, but sub-
lethal doses did not reliably induce empyema, increase 
pleural thickening or promote pleurodesis. Further, early 
mortality (euthanasia required by day 2) was observed in 
mice with pneumonia severe enough to induce empyema. 
Based on histological assessments, restriction in these 
mice was mainly due to pneumonia rather than advanced 
pleural remodeling.
Because sublethal intranasal infection failed to induce 
pleural injury, we next administered S. pneumoniae 
directly into the intrapleural space. It is important to 
note intrapleural delivery models clinical pleural infec-
tion that may occur with direct pleural infection, as 
occurs after penetrating chest trauma, chest tube or 
thoracentesis-related infections or with post-surgical 
complications. This route of administration was char-
acterized by the progressive accumulation of fibrinous 
material and increased WBCs in the pleural space by 
7  days after injury. Pleural organization was also appar-























Fig. 11 COX-2 and PGE2 are induced in human and murine PMCs by 
plasmin and uPA. a Serum-starved HPMCs were treated with plasmin 
(PLN, 7 nM) or uPA (20 nM) for 48 h. Lysates were then Western blot-
ted for COX-2. Akt was the loading control. b Conditioned media 
of cells treated with PBS, plasmin and uPA were analyzed for PGE2. 
Plasmin and uPA significantly increased PGE2 expression in HPMCs (* 
denotes a p < 0.05 when compared to PBS treated controls. n = 3/
treatment). c Serum-starved MPMCs were treated with murine 
plasmin (7 nM, PLN) and murine uPA (20 nM) for 48 h. Lysates were 
then subjected to western blotting for COX-2. β-actin was the loading 
control. d Conditioned media of cells treated with PBS, plasmin and 
uPA were probed for PGE2 by competitive ELISA. Plasmin and uPA sig-
nificantly increased PGE2 expression in MPMCs (*denotes a p < 0.05 
when compared to PBS treated controls)
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and by significant restrictive changes in pulmonary func-
tion by 7 days. Pleural adhesion formation and thickening 
and areas of pleurodesis were apparent at gross inspec-
tion and by histological analyses. Although significant 
decrements in lung function were observed at 3  days 
in infected WT mice, changes in lung volumes did not 
reach significance, likely attributable to modest changes 
in pleural organization that were found at that time. 
The significant decrements in lung volume and func-
tion demonstrated by infected PAI-1−/− mice at 3  days 
appeared to be due to the presence of pleural effusions 
rather than advanced pleural remodeling. The presence 
of purulent pleural effusions and increased pleural lav-
age neutrophilia in PAI-1−/− mice compared to WT 
mice demonstrates that local inflammation is worsened 
by PAI-1 deficiency. Although the bacterial burden in 
WT and PAI-1−/− was comparable at 3  days, septice-
mia was not excluded and represents a potential deter-
minant for increased mortality in PAI-1 deficient mice. 
While a range of mediators that could have contributed 
to increased pleural inflammation in the infected PAI-
1−/− mice were identified, increased pleural lavage PGE2 
Fig. 12 PGE2 induces MT of HPMCs and MPMCs. Serum-starved HPMCs were treated with PBS, PGE2 (1 μM ) and TGF-β (5 ng/ml) for 48 h. Cell 
lysates were cleared, measured and then resolved by SDS-PAGE. a α-SMA was increased in TGF-β and PGE2-treated HPMCs. β-actin was the loading 
control. Image is representative of three independent experiments. b MPMCs were serum starved for 24 h and then treated with PBS, TGF-β (5 ng/
ml) or PGE2 (1 μM) for 48 h. Lysates were then resolved via SDS-PAGE and probed for α-SMA. Akt was the loading control. Image is representative of 
two independent experiments. HPMCs were seeded on glass coverslips. Cells were serum starved for 24 h and then treated with PBS, PGE2 or TGF-β 
for 48 h. c PGE2 increased α-SMA expression by HPMCs and induced changes in cell morphology indicative of MesoMT. Images were taken at 40× 
and are representative of 30 fields/treatment. d Serum-starved HPMCs were treated with PBS, TGF-β (5 ng/ml) and sulprostone (EP3 agonist, 1 µM) 
for 48 h. Cell lysates were cleared, measured and then resolved by SDS-PAGE. α-SMA was increased in TGF-β and sulprostone-treated HPMCs. β-actin 
was the loading control. Image is representative of three independent experiments
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of these versus WT animals in particular likely contrib-
uted to that differential response. On the other hand, 
increased local elaboration of plasmin likely contributed 
to the decreased extravascular fibrin seen in the PAI-
1−/− animals with empyema (Fig. 8c), which could have 
impaired containment of the organisms and worsened 
outcomes. Lastly, it is likewise possible that local or sys-
temic elaboration of other factors could have contributed 
to the increased mortality in these animals.
Antibiotic administration was required to maintain 
mice with empyema over 3–14  days after intrapleural 
inoculation. While ampicillin (100  mg/kg) is an alterna-
tive antibiotic for the treatment of S. pneumoniae infec-
tion, its use required subcutaneous injection every 12 h. 
To minimize manipulation and distress in the infected 
mice, we chose to use the quinolone enrofloxacin (15 mg/
kg), which only required subcutaneous injection every 
24  h. We did not attempt to induce empyema in mice 
pre-treated with antibiotics. Although antibiotic treat-
ment cleared the bacterial infection by 3 days, decrements 
in lung function and pleural rind formation occurred 
even after clearance of viable organisms. This situation 
simulates the findings that can occur in complicated par-
apneumonic pleural effusions in patients that are predis-
posed to loculation. As expected, a range of inflammatory 
mediators were significantly increased by 3  days and 
tended to subside by 14 days after induction of empyema. 
Restrictive changes in lung function and pleural thick-
ness persisted at 14 days after induction of Streptococcal 
empyema, enabling assessment of pleural remodeling at 
subacute stages post-infection. While we did not carry the 
model forward, the animals were recovering from pleu-
ral infection at 14  days and could likely be maintained 
for even longer periods of time to assess the resolution of 
pleural injury. Studies to evaluate factors that contribute 
to progressive remodeling after induction of empyema 
over longer intervals are ongoing. Future studies will also 
include S. pneumoniae strains more commonly found in 
the clinical setting to determine if they likewise induce 
comparable pleural remodeling and survival.
In our previous reports, we showed that MesoMT 
contributed to the increased myofibroblast popula-
tion observed in human nonspecific pleuritis and in our 
carbon black/bleomycin pleural injury model [9, 17]. 
Further, MesoMT has been reported by others to be 
a key feature of pleural remodeling [23, 24]. Confocal 
analyses of tissue sections from S. pneumoniae-infected 
mice demonstrated increased α-SMA expression that 
colocalized within the pleural and subpleural regions, 
demonstrating that MesoMT occurred in WT mice by 
7 days after pleural infection. Myofibroblasts from other 
sources such as the lung interior or fibrocytes may also 
be present, but the data show that mesothelial cells con-
tribute to the process. These findings strongly suggest 
that pleural mesothelial cells undergo MesoMT and con-
tribute to pleural remodeling and rind formation that 
occur over 2 weeks following induction of empyema.
The model is tractable for the identification of novel 
pathways that may condition pleural remodeling. An 
example of that is provided by our data showing that 
PGE2 is not only locally expressed during the organiza-
tional phase of resolving empyema, as expected, but that 
it can influence remodeling by stimulating MesoMT and 
pleural rind expansion. Plasmin was detectable during 
this phase and was capable of inducing PGE2 elaboration 
by murine PMCs. Plasmin and PGE2 potently induced 
biomarkers of MesoMT as did TGF-β in our analyses. 
We found that PGE2 can contribute to organization and 
remodeling of the visceral pleura after S. pneumoniae–
induced injury in part by promoting MesoMT in an EP3-
specific manner. The ability of plasmin itself to induce 
pleural rind formation is likely limited by rapid inhibition 
of fibrinolytic activity leading to formation of an intra-
pleural fibrinous transition matrix at 7 or 14  days post 
infection, as demonstrated by the paucity of detectable 
fibrinolytic activity in in lung lavage.
In summary intrapleurally administered S. pneumoniae 
induced robust pleural remodeling. The model is also 
characterized by progressive matrix deposition, restric-
tive lung disease and durable pleural remodeling. Further, 
the use of antibiotics allows the study of injury progres-
sion for at least 14 days and perhaps over longer periods 
of time. The model enables the use of genetically modi-
fied animals, as demonstrated by analyses of the effects 
of PAI-1 deficiency in the model. We identified enhanced 
susceptibility to S. pneumoniae infection in PAI-1−/− 
mice and demonstrate that pleural inflammation was 
increased and likely due at least in part to overexpression 
of PGE2. Increased local elaboration of plasmin in the 
PAI-1−/− mice appears to have decreased extravascular 
fibrin deposition, which may have impaired containment 
of the infection within the pleural space. Apart from 
these effects, other local or systemic effects including sys-
temic sepsis could have contributed to increased mortal-
ity in the PAI-1−/− mice. In the aggregate, these findings 
demonstrate that the model is reliably characterized by 
pleural organization after the induction of pleural infec-
tion and enables dissection of local alterations involved 
in the organizational phase of pleural injury that follows 
Streptococcal empyema.
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